High level of tregs is a positive prognostic marker in patients with HPV-positive oral and oropharyngeal squamous cell carcinomas

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Lukesova, E ^a,b   Boucek, J ^a,c   Rotnaglova, E ^a   Salakova, M ^b   Koslabova, E ^a,b   Grega, M ^a   Eckschlager, T ^d   Rihova, B ^c   Prochazka, B ^b   Klozar, J ^a   Tachezy, R ^b  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^b INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^c INSTITUTE OF MICROBIOLOGY   (Czech Republic)

^d CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; MESSENGER RNA; PROTEIN E6; PROTEIN P16; VIRUS DNA; BIOLOGICAL MARKER; CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ADULT; ARTICLE; CANCER GRADING; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; FEMALE; FLOW CYTOMETRY; HEALTH STATUS; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 58; IMMUNOLOGICAL PARAMETERS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MOUTH CAVITY; MOUTH SQUAMOUS CELL CARCINOMA; NATURAL KILLER T CELL; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; PAPILLOMAVIRUS INFECTION; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TUMOR DIFFERENTIATION; AGE; BLOOD; CARCINOMA, SQUAMOUS CELL; DEMOGRAPHY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; NATURAL KILLER CELL; OROPHARYNGEAL NEOPLASMS; PAPILLOMA VIRUS; PHYSIOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REGRESSION ANALYSIS; SURVIVAL; VIROLOGY;

AGE FACTORS; BIOLOGICAL MARKERS; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DEMOGRAPHY; FEMALE; HUMANS; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; NEOPLASM GRADING; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; SURVIVAL ANALYSIS; T-LYMPHOCYTES, REGULATORY;

EID: 84901277424     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/303929     Document Type: Article

References (50)

1. Warnakulasuriya S., Global epidemiology of oral and oropharyngeal cancer. Oral Oncology 2009 45 4-5 309 316 2-s2.0-67349186933 10.1016/j.oraloncology. 2008.06.002
2. Zivile G., Janina D., Irina M., Saulius C., Raisa S., Aliaksandr Z., Prevalence of human papillomaviruses in patients with head and neck squamous cell carcinoma in Lithuania and Belarus. Journal of Medical Virology 2014 86 3 531 535 10.1002/jmv.23750
3. Hammarstedt L., Lindquist D., Dahlstrand H., Romanitan M., Onelöv L., Joneberg J., Creson N., Lindholm J., Ye W., Dalianis T., Munck-Wikland E., Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. International Journal of Cancer 2006 119 11 2620 2623 2-s2.0-33750616532 10.1002/ijc.22177 (Pubitemid 44691317)
4. Genden E. M., Sambur I. M., de Almeida J. R., Posner M., Rinaldo A., Rodrigo J. P., Human papillomavirus and oropharyngeal squamous cell carcinoma: what the clinician should know. European Archives of Oto-Rhino-Laryngology 2013 270 2 405 416 10.1007/s00405-012-2086-4
5. Näsman A., Attner P., Hammarstedt L., Du J., Eriksson M., Giraud G., Ährlund-Richter S., Marklund L., Romanitan M., Lindquist D., Ramqvist T., Lindholm J., Sparén P., Ye W., Dahlstrand H., Munck-Wikland E., Dalianis T., Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? International Journal of Cancer 2009 125 2 362 366 2-s2.0-67449090374 10.1002/ijc.24339
6. Chaturvedi A. K., Engels E. A., Anderson W. F., Gillison M. L., Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. Journal of Clinical Oncology 2008 26 4 612 619 2-s2.0-39149104081 10.1200/JCO.2007.14.1713 (Pubitemid 351264356)
7. Smith E. M., Ritchie J. M., Summersgill K. F., Klussmann J. P., Lee J. H., Wang D., Haugen T. H., Turek L. P., Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. International Journal of Cancer 2004 108 5 766 772 2-s2.0-0347915672 10.1002/ijc.11633 (Pubitemid 38076410)
8. Sivasithamparam J., Visk C. A., Cohen E. E., King A. C., Modifiable risk behaviors in patients with head and neck cancer. Cancer 2013 119 13 2419 2426 10.1002/cncr.27993
9. Rotnaglova E., Tachezy R., Salakova M., Prochazka B., Kosl'abova E., Vesela E., HPV involvement in tonsillar cancer: prognostic significance and clinically relevant markers. International Journal of Cancer Journal International Du Cancer 2011 129 101 110
10. Attner P., Du J., Näsman A., Hammarstedt L., Ramqvist T., Lindholm J., Marklund L., Dalianis T., Munck-Wikland E., Human papillomavirus and survival in patients with base of tongue cancer. International Journal of Cancer 2011 128 12 2892 2897 2-s2.0-79955450011 10.1002/ijc.25625
11. Plummer M., Schiffman M., Castle P. E., Maucort-Boulch D., Wheeler C. M., A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. Journal of Infectious Diseases 2007 195 11 1582 1589 2-s2.0-34249093548 10.1086/516784 (Pubitemid 46799215)
12. Saussez S., Duray A., Demoulin S., Hubert P., Delvenne P., Immune suppression in head and neck cancers: a review. Clinical and Developmental Immunology 2010 2010 15 2-s2.0-79955081407 10.1155/2010/701657 701657
13. Hoffmann T. K., Dworacki G., Tsukihiro T., Meidenbauer N., Gooding W., Johnson J. T., Whiteside T. L., Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance. Clinical Cancer Research 2002 8 8 2553 2562 2-s2.0-0036023415 (Pubitemid 34856339)
14. Whiteside T. L., Immunobiology of head and neck cancer. Cancer and Metastasis Reviews 2005 24 1 95 105 2-s2.0-17744380809 10.1007/s10555-005-5050-6 (Pubitemid 40576066)
15. Renoux V. M., Bisig B., Langers I., Dortu E., Clémenceau B., Thiry M., Deroanne C., Colige A., Boniver J., Delvenne P., Jacobs N., Human papillomavirus entry into NK cells requires CD16 expression and triggers cytotoxic activity and cytokine secretion. European Journal of Immunology 2011 41 11 3240 3252 2-s2.0-80054887028 10.1002/eji.201141693
16. Textor S., Dürst M., Jansen L., Accardi R., Tommasino M., Trunk M. J., Porgador A., Watzl C., Gissmann L., Cerwenka A., Activating NK cell receptor ligands are differentially expressed during progression to cervical cancer. International Journal of Cancer 2008 123 10 2343 2353 2-s2.0-53449094978 10.1002/ijc.23733
17. Wulff S., Pries R., Börngen K., Trenkle T., Wollenberg B., Decreased levels of circulating regulatory NK cells in patients with head and neck cancer throughout all tumor stages. Anticancer Research 2009 29 8 3053 3057 2-s2.0-68549117138
18. Accomando W. P., Wiencke J. K., Houseman E. A., Butler R. A., Zheng S., Nelson H. H., Decreased NK cells in patients with head and neck cancer determined in archival DNA. Clinical Cancer Research 2012 18 6147 6154
19. Molling J. W., Langius J. A. E., Langendijk J. A., Leemans C. R., Bontkes H. J., Van Der Vliet H. J. J., Von Blomberg B. M. E., Scheper R. J., Van Den Eertwegh A. J. M., Low levels of circulating invariant natural killer T cells predict poor clinical outcome in patients with head and neck squamous cell carcinoma. Journal of Clinical Oncology 2007 25 7 862 868 2-s2.0-33947523413 10.1200/JCO.2006.08.5787 (Pubitemid 350002887)
20. Liyanage U. K., Moore T. T., Joo H.-G., Tanaka Y., Herrmann V., Doherty G., Drebin J. A., Strasberg S. M., Eberlein T. J., Goedegebuure P. S., Linehan D. C., Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. Journal of Immunology 2002 169 5 2756 2761 2-s2.0-0036721629 (Pubitemid 34921025)
21. + T regulatory cells show strong prognostic significance in colorectal cancer. Journal of Clinical Oncology 2009 27 2 186 192 2-s2.0-58249089749 10.1200/JCO.2008.18.7229
22. + regulatory T cells in the peripheral blood of advanced stage lung cancer patients. Medical Oncology 2010 27 1 29 33 2-s2.0-77949266099 10.1007/s12032-008-9165-9
23. +) cytotoxic T cells predicts poor survival and high recurrence rates in patients with hepatocellular carcinoma. Hepatology 2013 58 1 139 149 10.1002/hep.26054
24. Ladányi A., Somlai B., Gilde K., Fejös Z., Gaudi I., Tímár J., T-cell activation marker expression on tumor-infiltrating lymphocytes as prognostic factor in cutaneous malignant melanoma. Clinical Cancer Research 2004 10 2 521 530 2-s2.0-0842268394 10.1158/1078-0432.CCR-1161-03 (Pubitemid 38173990)
25. Bhairavabhotla R. K., Verma V., Tongaonkar H., Shastri S., Dinshaw K., Chiplunkar S., Role of IL-10 in immune suppression in cervical cancer. Indian Journal of Biochemistry and Biophysics 2007 44 5 350 356 2-s2.0-41649106969 (Pubitemid 351481352)
26. high regulatory T cells in nasopharyngeal carcinoma patients. British Journal of Cancer 2007 96 4 617 622 2-s2.0-33847183114 10.1038/sj.bjc.6603580
27. + regulatory T cells in the peripheral circulation of patients with head and neck cancer. British Journal of Cancer 2005 92 5 913 920 2-s2.0-16244409219 10.1038/sj.bjc.6602407 (Pubitemid 40462639)
28. + T cells in the circulation of patients with squamous cell carcinoma of the head and neck. Clinical Cancer Research 2007 13 21 6301 6311 2-s2.0-35948952840 10.1158/1078-0432.CCR-07-1403 (Pubitemid 350075018)
29. Boucek J., Mrkvan T., Chovanec M., Kuchar M., Betka J., Boucek V., Hladikova M., Betka J., Eckschlager T., Rihova B., Regulatory T cells and their prognostic value for patients with squamous cell carcinoma of the head and neck. Journal of Cellular and Molecular Medicine 2010 14 1-2 426 433 2-s2.0-77951968197 10.1111/j.1582-4934.2008.00650.x
30. + T-cell subpopulations in head and neck cancers. Clinical Cancer Research 2006 12 2 465 472 2-s2.0-31544455880 10.1158/1078-0432.CCR-05-1886 (Pubitemid 43166137)
31. Zhang Y.-L., Li J., Mo H.-Y., Qiu F., Zheng L.-M., Qian C.-N., Zeng Y.-X., Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways. Molecular Cancer 2010 9, article 4 2-s2.0-76749156695 10.1186/1476-4598-9-4
32. Wamsom D., Light E., Thomas D., Worden F., Prince M., Urba S., Chepeha D., Kumar B., Cordell K., Eisbruch A., Taylor J., Moyer J., Bradford C., D'Silva N., Carey T., McHugh J., Wolf G., Infiltrating lymphocytes and human papillomavirus-16-associated oropharyngeal cancer. Laryngoscope 2012 122 1 121 127 2-s2.0-84255204907 10.1002/lary.22133
33. + lymphocytes correlate to clinical outcome and human papillomavirus (HPV) status in tonsillar cancer. PloS ONE 2012 7 e38711
34. Aarstad H. J., Heimdal J.-H., Klementsen B., Olofsson J., Ulvestad E., Presence of activated T lymphocytes in peripheral blood of head and neck squamous cell carcinoma patients predicts impaired prognosis. Acta Oto-Laryngologica 2006 126 12 1326 1333 2-s2.0-33751085890 10.1080/ 00016480600702092 (Pubitemid 44764334)
35. Green V. L., Michno A., Stafford N. D., Greenman J., Increased prevalence of tumour infiltrating immune cells in oropharyngeal tumours in comparison to other subsites: relationship to peripheral immunity. Cancer Immunology, Immunotherapy 2013 62 863 873
36. Koslabova E., Hamsikova E., Salakova M., Klozar J., Foltynova E., Salkova E., Markers of HPV infection and survival in patients with head and neck tumours. International Journal of Cancer 2013 133 8 1832 1839
37. Klozar J., Kratochvil V., Salakova M., Smahelova J., Vesela E., Hamsikova E., Betka J., Tachezy R., HPV status and regional metastasis in the prognosis of oral and oropharyngeal cancer. European Archives of Oto-Rhino-Laryngology 2008 265 1 S75 S82 2-s2.0-47349093222 10.1007/s00405-007-0557-9
38. Tachezy R., Klozar J., Saláková M., Smith E., Turek L., Betka J., Kodet R., Hamšíková E., HPV and other risk factors of oral cavity/oropharyngeal cancer in the Czech Republic. Oral Diseases 2005 11 3 181 185 2-s2.0-20144374287 (Pubitemid 40776330)
39. + PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. Journal of Clinical Microbiology 2002 40 3 779 787 2-s2.0-0036197930 10.1128/JCM.40.3.779-787.2002 (Pubitemid 34208623)
40. Gravitt P. E., Peyton C., Wheeler C., Apple R., Higuchi R., Shah K. V., Reproducibility of HPV 16 and HPV 18 viral load quantitation using TaqMan real-time PCR assays. Journal of Virological Methods 2003 112 1-2 23 33 2-s2.0-0242348847 10.1016/S0166-0934(03)00186-1 (Pubitemid 37338255)
41. Smeets S. J., Hesselink A. T., Speel E.-J. M., Haesevoets A., Snijders P. J. F., Pawlita M., Meijer C. J. L. M., Braakhuis B. J. M., Leemans C. R., Brakenhoff R. H., A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. International Journal of Cancer 2007 121 11 2465 2472 2-s2.0-35648937953 10.1002/ijc.22980 (Pubitemid 350022416)
42. Raghavan S., Quiding-Jädierbrink M., Regulatory T cells in gastrointestinal tumors. Expert Review of Gastroenterology and Hepatology 2011 5 4 489 501 2-s2.0-79960764022 10.1586/egh.11.44
43. + regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer. Cancer Immunology, Immunotherapy 2011 60 7 909 918 2-s2.0-79959742164 10.1007/s00262-011-1046-y
44. + Tregs in lymphomas and tumors are complex. Frontiers in Bioscience 2008 13 10 3986 4001 2-s2.0-42649131674 10.2741/2986 (Pubitemid 351594676)
45. Álvaro T., Lejeune M., Salvadó M. T., Bosch R., García J. F., Jaén J., Banham A. H., Roncador G., Montalbán C., Piris M. A., Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Clinical Cancer Research 2005 11 4 1467 1473 2-s2.0-20044367117 10.1158/1078-0432.CCR-04-1869 (Pubitemid 40315228)
46. + regulatory T cells at the single-cell level. European Journal of Immunology 2005 35 6 1681 1691 2-s2.0-20844432429 10.1002/eji.200526189 (Pubitemid 40862316)
47. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M., Pillars article: immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995. Journal of Immunology 2011 186 3808 3821
48. Smith E. M., Rubenstein L. M., Haugen T. H., Pawlita M., Turek L. P., Complex etiology underlies risk and survival in head and neck cancer human papillomavirus, tobacco, and alcohol: a case for multifactor disease. Journal of Oncology 2012 2012 9 2-s2.0-84858251423 10.1155/2012/571862 571862
49. Hoffmann M., Tribius S., Quabius E. S., Henry H., Pfannenschmidt S., Burkhardt C., Görögh T., Halec G., Hoffmann A. S., Kahn T., Röcken C., Haag J., Waterboer T., Schmitt M., HPV DNA, E6I-mRNA expression and p16INK4A immunohistochemistry in head and neck cancer-how valid is p16INK4A as surrogate marker? Cancer Letters 2012 323 1 88 96 2-s2.0-84860548374 10.1016/j.canlet.2012.03.033
50. Ames E., Murphy W. J., Advantages and clinical applications of natural killer cells in cancer immunotherapy. Cancer Immunology, Immunotherapy 2014 63 1 21 28